2.53
price up icon4.12%   0.10
after-market アフターアワーズ: 2.42 -0.11 -4.35%
loading

Syros Pharmaceuticals Inc (SYRS) 最新ニュース

pulisher
Nov 04, 2024

Syros Pharmaceuticals (NASDAQ:SYRS) Rating Lowered to Sell at StockNews.com - MarketBeat

Nov 04, 2024
pulisher
Nov 04, 2024

SYRS (Syros Pharmaceuticals) Total Inventories : $0.00 Mil (As of Sep. 2024) - GuruFocus.com

Nov 04, 2024
pulisher
Nov 04, 2024

Syros Pharmaceuticals, Inc. (NASDAQ:SYRS) Q3 2024 Earnings Call Transcript - MSN

Nov 04, 2024
pulisher
Nov 04, 2024

Syros Pharmaceuticals, Inc. announced that it expects to receive $10 million in funding from Incyte Corporation - Marketscreener.com

Nov 04, 2024
pulisher
Nov 03, 2024

Incyte Corporation and yros Pharmaceuticals Announce Global Target Discovery and Validation Collaboration Focused on Myeloproliferative Neoplasms - Marketscreener.com

Nov 03, 2024
pulisher
Nov 02, 2024

SYRSW (Syros Pharmaceuticals) 5-Year Dividend Growth Rate : 0.00% (As of Jun. 2024) - GuruFocus.com

Nov 02, 2024
pulisher
Nov 02, 2024

Syros Pharmaceuticals Third Quarter 2024 Earnings: US$0.16 loss per share (vs US$1.43 loss in 3Q 2023) - Yahoo Finance

Nov 02, 2024
pulisher
Nov 01, 2024

Syros Pharmaceuticals (NASDAQ:SYRS) Issues Quarterly Earnings Results - MarketBeat

Nov 01, 2024
pulisher
Nov 01, 2024

Earnings call: Syros Pharmaceuticals outlines tamibarotene progress - Investing.com

Nov 01, 2024
pulisher
Nov 01, 2024

Syros Pharmaceuticals Inc (SYRS) Q3 2024 Earnings Call Highlights: Strategic Focus on ... - Yahoo Finance

Nov 01, 2024
pulisher
Nov 01, 2024

Syros Pharmaceuticals (NASDAQ:SYRS) Earns Buy Rating from HC Wainwright - MarketBeat

Nov 01, 2024
pulisher
Nov 01, 2024

Syros Pharmaceuticals Inc (SYRS) Q3 2024 Earnings Call Highlight - GuruFocus.com

Nov 01, 2024
pulisher
Nov 01, 2024

Syros Pharmaceuticals Reports Q3 2024 Financial Results - TipRanks

Nov 01, 2024
pulisher
Oct 31, 2024

Q3 2024 Syros Pharmaceuticals Inc Earnings Call Transcript - GuruFocus.com

Oct 31, 2024
pulisher
Oct 31, 2024

Syros Reports Third Quarter 2024 Financial Results and Provides a Business Update - StockTitan

Oct 31, 2024
pulisher
Oct 31, 2024

Syros Pharmaceuticals, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Oct 31, 2024
pulisher
Oct 25, 2024

Syros Pharmaceuticals (SYRS) Loses -70.55% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner - MSN

Oct 25, 2024
pulisher
Oct 25, 2024

Syros Pharmaceuticals (SYRS) Set to Announce Earnings on Thursday - MarketBeat

Oct 25, 2024
pulisher
Oct 25, 2024

Syros Pharmaceuticals' SWOT analysis: stock outlook amid clinical setbacks - Investing.com India

Oct 25, 2024
pulisher
Oct 24, 2024

Syros Pharmaceuticals' SWOT analysis: stock outlook amid clinical setbacks By Investing.com - Investing.com Australia

Oct 24, 2024
pulisher
Oct 23, 2024

Piper Sandler reaffirms overweight rating and $5 PT on Syros Pharmaceuticals stock - Investing.com UK

Oct 23, 2024
pulisher
Oct 15, 2024

Syros Pharmaceuticals (NASDAQ:SYRS) Upgraded by StockNews.com to "Hold" - MarketBeat

Oct 15, 2024
pulisher
Oct 09, 2024

Syros Pharmaceuticals Inc (SYRS) Q2 2024 Earnings Call Highlights: Strategic Focus on ... - Yahoo Finance

Oct 09, 2024
pulisher
Oct 07, 2024

Syros Pharmaceuticals (NASDAQ:SYRS) Downgraded by StockNews.com - MarketBeat

Oct 07, 2024
pulisher
Oct 02, 2024

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Syros Pharmaceuticals, Inc.SYRS - cnhinews.com

Oct 02, 2024
pulisher
Sep 30, 2024

Syros Pharmaceuticals' SWOT analysis: stock faces challenges amid clinical setbacks By Investing.com - Investing.com South Africa

Sep 30, 2024
pulisher
Sep 30, 2024

Syros Pharmaceuticals' SWOT analysis: stock faces challenges amid clinical setbacks - Investing.com India

Sep 30, 2024
pulisher
Sep 24, 2024

575,000 Shares in Spyre Therapeutics, Inc. (NASDAQ:SYRE) Bought by Logos Global Management LP - Defense World

Sep 24, 2024
pulisher
Sep 24, 2024

Ratios Uncovered: Breaking Down Spyre Therapeutics Inc. (SYRE)’s Trailing Twelve Months Metrics - The Dwinnex

Sep 24, 2024
pulisher
Sep 24, 2024

Symphony Environmental Technologies (LON:SYM) Shares Down 13.8% - Defense World

Sep 24, 2024
pulisher
Sep 24, 2024

Spyre Therapeutics Inc.’s results are impressive - US Post News

Sep 24, 2024
pulisher
Sep 24, 2024

Farallon Capital Management LLC Buys Shares of 666,000 Spyre Therapeutics, Inc. (NASDAQ:SYRE) - MarketBeat

Sep 24, 2024
pulisher
Sep 23, 2024

100,000 Shares in Spyre Therapeutics, Inc. (NASDAQ:SYRE) Purchased by Integral Health Asset Management LLC - Defense World

Sep 23, 2024
pulisher
Sep 23, 2024

Spyre Therapeutics (NASDAQ:SYRE) Shares Gap Down to $30.17 - MarketBeat

Sep 23, 2024
pulisher
Sep 23, 2024

Xilio Therapeutics Inc (XLO) rating initates by Chardan Capital Markets - Knox Daily

Sep 23, 2024
pulisher
Sep 23, 2024

Itau Unibanco Holding S.A. Takes $435,000 Position in Ross Stores, Inc. (NASDAQ:ROST) - Defense World

Sep 23, 2024
pulisher
Sep 23, 2024

Avoro Capital Advisors LLC Purchases Shares of 1,839,138 Spyre Therapeutics, Inc. (NASDAQ:SYRE) - Defense World

Sep 23, 2024
pulisher
Sep 23, 2024

Canada Pension Plan Investment Board Acquires 509,700 Shares of Symbotic Inc. (NASDAQ:SYM) - Defense World

Sep 23, 2024
pulisher
Sep 21, 2024

Symbotic (NASDAQ:SYM) Shares Up 2.1% - Defense World

Sep 21, 2024
pulisher
Sep 20, 2024

Arm Joins the PHLX Semiconductor Sector Index℠ (SOX℠) - sharewise

Sep 20, 2024
pulisher
Sep 19, 2024

The Principles of Low-Carbon Tectonics: As Lygos, Pyran accelerate, we look at the why, the where, and the when - Biofuels Digest

Sep 19, 2024
pulisher
Sep 19, 2024

Symbotic (NASDAQ:SYM) Shares Gap Up to $22.41 - Defense World

Sep 19, 2024
pulisher
Sep 18, 2024

Quarterly Metrics: Quick and Current Ratios for Symbotic Inc (SYM) - The Dwinnex

Sep 18, 2024
pulisher
Sep 18, 2024

Wall Street analysts’ outlook for Symbotic Inc (SYM) - SETE News

Sep 18, 2024
pulisher
Sep 17, 2024

Understanding the Risks of Investing in Syros Pharmaceuticals Inc. (SYRS) - Knox Daily

Sep 17, 2024
pulisher
Sep 17, 2024

Siyata Mobile Inc (SYTA) expanding its growth trajectory ahead - SETE News

Sep 17, 2024
pulisher
Sep 17, 2024

What is the investor’s view on Syros Pharmaceuticals Inc. (SYRS)? - US Post News

Sep 17, 2024
pulisher
Sep 14, 2024

Syros Pharmaceuticals Chief Financial Officer Acquires 407% More Stock - Simply Wall St

Sep 14, 2024
pulisher
Sep 13, 2024

Syros Pharmaceuticals Inc. [SYRS] Shares Fall Approximately -60.45% Over the Year - Knox Daily

Sep 13, 2024
pulisher
Sep 13, 2024

Syros Pharmaceuticals Inc.’s Shares Reel: -70.93% Quarterly Revenue Decline Amid 41.97M Market Cap - The InvestChronicle

Sep 13, 2024
pulisher
Sep 13, 2024

Syros pharmaceuticals CEO buys shares worth over $160k By Investing.com - Investing.com Australia

Sep 13, 2024
pulisher
Sep 13, 2024

SYRS underperforms with a -2.18 decrease in share price - US Post News

Sep 13, 2024
pulisher
Sep 13, 2024

Syros pharmaceuticals CEO buys shares worth over $160k - Investing.com

Sep 13, 2024
pulisher
Sep 13, 2024

Syros Pharmaceuticals CFO buys shares worth over $161k - Investing.com

Sep 13, 2024
pulisher
Sep 13, 2024

Insider Buying: President & CEO Conley Chee Acquires Shares of S - GuruFocus.com

Sep 13, 2024
pulisher
Sep 12, 2024

Insider Buying: CFO Jason Haas Acquires 100,000 Shares of Syros Pharmaceuticals Inc (SYRS) - Yahoo Finance

Sep 12, 2024
pulisher
Sep 12, 2024

Insider Buying: President & CEO Conley Chee Acquires Shares of Syros Pharmaceuticals Inc (SYRS) - Yahoo Finance

Sep 12, 2024
pulisher
Sep 12, 2024

Insider Buying: CFO Jason Haas Acquires 100,000 Shares of Syros Pharmaceuticals Inc (SYRS) By GuruFocus - Investing.com Canada

Sep 12, 2024
pulisher
Sep 12, 2024

Insider Buying: President & CEO Conley Chee Acquires Shares of Syros Pharmaceuticals Inc (SYRS) By GuruFocus - Investing.com Canada

Sep 12, 2024
pulisher
Sep 12, 2024

Syros Pharmaceuticals CFO buys shares worth over $161k By Investing.com - Investing.com Canada

Sep 12, 2024
pulisher
Sep 10, 2024

Syros Pharmaceuticals stock hits 52-week low at $1.48 By Investing.com - Investing.com Australia

Sep 10, 2024
pulisher
Sep 10, 2024

Syros Pharmaceuticals stock hits 52-week low at $1.48 - Investing.com

Sep 10, 2024
$77.28
price up icon 2.02%
$20.39
price up icon 2.15%
$382.77
price up icon 1.58%
$53.29
price down icon 0.47%
$208.03
price up icon 0.38%
$110.97
price up icon 1.84%
大文字化:     |  ボリューム (24 時間):